Demet US, Barkın BERK, Ece GÜRDAL, Nihan AYTEKIN, Tanıl KOCAGÖZ, Berrak ÇAĞLAYAN, İşıl AKSAN KURNAZ, Dilek DEMİR EROL

8394

Mannich base derivatives of 3-hydroxy-6- methyl-4H-pyran-4-one with antimicrobial activity

A series of 3-hydroxy-6-methyl-2-[(substitutedpiperidine-1-yl) methyl]-4H-pyran-4-one structured compounds were synthesized by reacting 5-hydroxy-2-methyl-4H-pyran-4-one with suitable piperidine derivatives using Mannich reaction conditions. Antibacterial activities of the compounds for E. coli ATCC 25922, S. paratyphi ATCC BAA-1250, S. flexneri ATCC 12022, E. gergoviae ATCC 33426, and M. smegmatis ATCC 14468 were assessed in vitro by the broth dilution method for determination of minimum inhibitory concentration (MIC). In addition, their inhibitory effects over DNA gyrase enzyme were evaluated using a DNA gyrase supercoiling assay. All the synthesized compounds showed a MIC value of either 8 or 16 m g/mL for M. smegmatis, whereas minimum to moderate activity was achieved for the others. Those tested in the supercoiling assay had at best a very mild inhibition of the enzyme. This series deserves further attention for testing over Mycobacterium species and topoisomerase II inhibition to develop new lead drugs to treat non-tuberculous mycobacterial infections.
Anahtar Kelimeler:

Antimycobacterial and antibacterial activity; DNA gyrase activity; Mannich bases of 3-hydroxy-4H-pyran-4-one.

Mannich base derivatives of 3-hydroxy-6- methyl-4H-pyran-4-one with antimicrobial activity

A series of 3-hydroxy-6-methyl-2-[(substitutedpiperidine-1-yl) methyl]-4H-pyran-4-one structured compounds were synthesized by reacting 5-hydroxy-2-methyl-4H-pyran-4-one with suitable piperidine derivatives using Mannich reaction conditions. Antibacterial activities of the compounds for E. coli ATCC 25922, S. paratyphi ATCC BAA-1250, S. flexneri ATCC 12022, E. gergoviae ATCC 33426, and M. smegmatis ATCC 14468 were assessed in vitro by the broth dilution method for determination of minimum inhibitory concentration (MIC). In addition, their inhibitory effects over DNA gyrase enzyme were evaluated using a DNA gyrase supercoiling assay. All the synthesized compounds showed a MIC value of either 8 or 16 m g/mL for M. smegmatis, whereas minimum to moderate activity was achieved for the others. Those tested in the supercoiling assay had at best a very mild inhibition of the enzyme. This series deserves further attention for testing over Mycobacterium species and topoisomerase II inhibition to develop new lead drugs to treat non-tuberculous mycobacterial infections.
Keywords:

Antimycobacterial and antibacterial activity; DNA gyrase activity; Mannich bases of 3-hydroxy-4H-pyran-4-one.,

PDF

___

  • Katoch, V. M. Indian J. Med. Res. 2004, 120, 290-304.
  • Wallace, R. J. Jr.; O’Brein, R.; Glassroth, J.; Raleigh, J.; Dutta, A. Am. Rev. Respir. Dis. 1990, 142, 940-953.
  • Katoch, V. M.; Mohan, K. T. A typical mycobacterial infections. Sharma, S. K., Eds.; Tuberculosis, Jaypee Brothers Medical Publishers (P) Ltd, New Delhi, 2001.
  • Khan, K.; Wang, J.; Marras, T. K. Am. J. Respir. Crit. Care Med. 2007, 176, 306-313.
  • Behr, M. A. Microbes Infect. 2008, 10, 968-972.
  • Kayser, F. H. Medical Microbiology, Georg Thieme Verlag, Stuttgart, 2005.
  • Besra, G. S.; Chatterjee, D. Lipids and carbohydrates of Mycobacterium tuberculosis; Bloom, B. R., Ed.; Tubercu- losis, ASM Press, Washington, DC, 1994.
  • Maxwell, A. Trends Microbiol. 1997,5, 102-109.
  • Aubry, A.; Fisher, L. M.; Jarlier, V.; Cambau, E. Biochem. Biophys. Res. Commun. 2006, 348, 158-165.
  • Cole, S. T.; Brosch, R.; Parkhill, J.; Garnier, T.; Churcher, C.; Harris, D.; Gordon, S. V.; Eiglmeier, K.; Gas, S.; Barry, C. E.; Tekaia, F.; Badcock, K.; Basham, D.; Brown, D.; Chillingworth, T.; Connor, R.; Davies, R.; Devlin, K.; Feltwell, T.; Gentles, S.; Hamlin, N.; Holroyd, S.; Hornsby, T.; Jagels, K.; Krogh, A.; McLean, J.; Moule, S.; Murphy, L.; Oliver, K.; Osborne, J.; Quail, M. A.; Rajandream, M. A.; Rogers, J.; Rutter, S.; Seeger; K.; Skelton, J.; Squares, R.; Squares, S.; Sulston, J. E.; Taylor, K.; Whitehead, S.; Barrell, B. G. et al. Nature 1998, 393, 544.
  • Yabuta, T. J. Chem. Soc. 1924, 125, 575-587.
  • Kayahara, H.; Shibata, N.; Tadasa, K.; Maeda, H.; Kotani, T.; Ichimoto, I. Agric. Biol. Chem. 1990, 54, 2441-2442.
  • Kotani, T.; Ichimoto, I.; Tatsumi, C.; Fujita, T. Agric. Biol. Chem. 1975, 39, 1311-1317.
  • Aytemir, M. D.; Hider, R. C.; Erol, D. D.; ¨Ozalp, M.; Ekizo˘glu, M. Turk J. Chem. 2003, 27, 445-452.
  • Aytemir, M. D.; Erol, D. D.; Hider, R. C.; ¨Ozalp, M. Turk J. Chem. 2003, 27, 757-764.
  • Wan, H. M.; Chen, C. C.; Giridhar, R.; Chang, T. S.; Wu, W. T. J. Ind. Microbiol. Biotechnol. 2005, 32, 227-233.
  • Yamato, M.; Yasumoto, Y.; Sakai, J.; Luduena, R. F.; Baneerjee, A.; Tashiro, T. J. Med. Chem. 1987, 30, 1897
  • Tamura, T.; Mitsumori, K.; Totsuka, Y.; Wakabayashi, K.; Kido, R.; Kasai, H.; Nasu, M.; Hirose, M. Toxicology , 222, 213-224. Aytemir, M. D.; C¸ alı¸s, ¨U.; ¨Ozalp, M. Arch. Pharm. Pharm. Med. Chem. 2004, 337, 281-288.
  • Aytemir, M. D.; C¸ alı¸s, ¨U. Hacettepe University Journal of the Faculty of Pharmacy 2007, 27, 1-10.
  • Aytemir, M. D.; C¸ alı¸s, ¨U. FABAD J. Pharm. Sci. 2006, 31, 23-29.
  • Kim, H.; Choi, J.; Cho, J. K.; Kim, S. Y.; Lee, Y. S. Bioorg. Med. Chem. Lett. 2004, 14, 2843-2846.
  • Moggia, F.; Brisset, H.; Fages, F.; Chaix, C.; Mandrand, B.; Dias, M.; Levillain, E. Tetrahedron Lett. 2006, 47, 3374.
  • Ellis, B. L.; Duhme, A. K.; Hider, R. C.; Hossain, M. B.; Rizvi, S.; Van Der Helm, D. J. Med. Chem. 1996, 39, 3670.
  • O’Brien, G.; Patterson, J. M.; Meadow, J. R. J. Org. Chem. 1960, 25, 86-89.
  • Moggia, F.; Brisset, H.; Fages, F.; Chaix, C.; Mandrand, B.; Dias, M.; Levillain, E. Tetrahedron Lett. 2006, 47, 3374.
  • Zborowski, K.; Grybos, R.; Proniewicz, L. M. Inorg. Chem. Commun. 2005, 8, 76-78.
  • Erol, D. D.; Yulu˘g, N. Eur. J. Med. Chem. 1994, 29, 893-897.
  • Liu, Z. D.; Piyamongkol, S.; Liu, D. Y.; Khodr, H. H.; Lu, S. H.; Hider, R. C. Bioorg. Med. Chem. 2001, 9, 573.
Turkish Journal of Chemistry-Cover
  • ISSN: 1300-0527
  • Yayın Aralığı: 6
  • Yayıncı: TÜBİTAK
Arşiv
Sayıdaki Diğer Makaleler

An efficient one-pot synthesis of dihydropyrimidinones catalyzed by zirconium hydrogen phosphate under solvent-free conditions

Şenol BEŞOLUK, Mustafa KÜÇÜKİSLAMOĞLU, Mustafa ZENGİN

Evaluation of solid-phase extraction sorbent with ketoimine groups for the preconcentration of benzene and phenolic compounds in water

İwona RYKOWSKA, Wiesllaw WASIAK

Synthesis and characterization of hybrid congo red from chloro-functionalized silsesquioxanes

Ahmet GÜLTEK

A theoretical study of the effects of polar substitution on the activation barriers for internal rotation around the C-N bond in p-substituted nitrosobenzenes: comparison of DFT and MP2 calculations

Şafak Özhan Kocakaya And Necmettin PİRİNÇÇİOĞLU

Molecular recognition of aromatic amines by coumarin substituted azacrown ether

Hiten MEHTA, Harjinder Kaur And Shobhana MENON

Picolyl substituted N-heterocyclic carbene/palladium catalyzed Heck reactions

Beyhan YİĞİT, Murat YİĞİT, İsmail Özdemir And Engin ÇETİNKAYA

Synthesis, characterisation, and structural elucidation by spectral investigation (FT-IR, multinuclear NMR, mass spectrometry) of biologically active organotin(IV) compounds containing germanium

Muhammad Kaleem KHOSA, Muhammad MAZHAR, Saqib ALI

Synthesis, characterization, antibacterial and antifungal evaluation of some new platinum(II) complexes of 2-phenylbenzimidazole ligands

Semra UTKU, Mustafa TOPAL, Aylin DÖĞEN

(E)-3-[(3-(Trifluoromethyl)phenylimino)methyl] benzene-1,2-diol: X-ray and DFT calculated structures

Başak KOŞAR, Çiğdem ALBAYRAK, Mustafa Odabaşoğlu AND

Synthesis and antimicrobial activities of 2-(5-mercapto)-1,3-oxadiazol-2-ylmethyl-1,2,4-triazol-3-one derivatives

Ahmet DEMİRBAŞ, Deniz ŞAHİN, Neslihan DEMİRBAŞ